Cardinal Health, Inc. CAH is set to release earnings results for its fourth quarter, before the opening bell on Aug. 14, 2024.
Analysts expect the Dublin, Ohio-based company to report quarterly earnings at $1.73 per share, up from $1.55 per share in the year-ago period. Cardinal Health is expected to report quarterly revenue of $58.64 billion for the quarter, compared to $53.45 billion a year earlier, according to data from Benzinga Pro.
On May 7, Cardinal Health approved an increase to its quarterly dividend from $0.5006 to $0.5056 per share.
Cardinal Health shares gained 1.9% to close at $102.58 on Tuesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
- Baird analyst Eric Coldwell maintained an Outperform rating and raised the price target from $129 to $130 on July 9. This analyst has an accuracy rate of 66%.
- Argus Research analyst David Toung maintained a Buy rating and cut the price target from $120 to $115 on May 15. This analyst has an accuracy rate of 69%.
- Wells Fargo analyst Stephen Baxter maintained an Underweight rating and slashed the price target from $96 to $94 on April 29. This analyst has an accuracy rate of 63%.
- UBS analyst Kevin Caliendo maintained a Buy rating and increased the price target from $122 to $125 on Feb. 5. This analyst has an accuracy rate of 69%.
- Mizuho analyst Ann Hynes maintained a Neutral rating and boosted the price target from $95 to $104 on Nov. 6. 2023. This analyst has an accuracy rate of 76%.
Considering buying CAH stock? Here’s what analysts think:
Read This Next:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.